antibody Lab Reagents for Research





Promoted Lab recombinants

ASAP1 antibody Antibody

DF8746 Affbiotech 200ul 420 EUR

CD11b Antibody Antibody

ABD2911 Lifescience Market 100 ug 525.6 EUR

anti- Antibody^Polyclonal antibody control antibody

LSMab09882 Lifescience Market 100 ug 525.6 EUR

ARHGDIA Antibody / RHOGDI Antibody

F54788-0.08ML NSJ Bioreagents 0.08 ml 165 EUR

ARHGDIA Antibody / RHOGDI Antibody

F54788-0.4ML NSJ Bioreagents 0.4 ml 379 EUR

Antibody

A1360-500 Biovision Ask for price

ASAP1 antibody Antibody

DF8746 Affbiotech 200ul 420 EUR

CD11b Antibody Antibody

ABD2911 Lifescience Market 100 ug 525.6 EUR

anti- Antibody^Polyclonal antibody control antibody

LSMab09882 Lifescience Market 100 ug 525.6 EUR

ARHGDIA Antibody / RHOGDI Antibody

F54788-0.08ML NSJ Bioreagents 0.08 ml 165 EUR

ARHGDIA Antibody / RHOGDI Antibody

F54788-0.4ML NSJ Bioreagents 0.4 ml 379 EUR

Antibody

A1360-500 Biovision Ask for price

Ly1 Antibody Reactive (LYAR) Antibody

20-abx123734 Abbexa
  • 493.20 EUR
  • 710.40 EUR
  • 100 ul
  • 200 ul

Our used rec. in Pubmed.

DERMATOPHYTE TEST AGAR

D04-107-500g Alphabiosciences 500 g 116.4 EUR

MOTILITY TEST MEDIUM

M13-121-10kg Alphabiosciences 10 kg 1833.6 EUR

MOTILITY TEST MEDIUM

M13-121-2Kg Alphabiosciences 2 Kg 445.2 EUR

MOTILITY TEST MEDIUM

M13-121-500g Alphabiosciences 500 g 164.4 EUR

SNYDER TEST AGAR

S19-119-10kg Alphabiosciences 10 kg 1258.8 EUR

SNYDER TEST AGAR

S19-119-2Kg Alphabiosciences 2 Kg 320.4 EUR

SNYDER TEST AGAR

S19-119-500g Alphabiosciences 500 g 130.8 EUR

SAM Test Strip

TS00201s-30 Arthus 30 tests 499.2 EUR

SAH Test Strip

TS00301s-30 Arthus 30 tests 604.8 EUR

HCY Test Strip

TS00401s-30 Arthus 30 tests 663.6 EUR

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post

Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity

Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activityTargeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity

Ewing sarcoma (EWS), a extremely aggressive pediatric tumor, is pushed by EWS-FLI1, an oncogenic transcription issue that remodels the tumor genetic panorama. Epigenetic mechanisms play a pivotal function in EWS

Liquid droplet formation and facile cytosolic translocation of IgG in the presence of attenuated cationic amphiphilic lytic peptides

Liquid droplet formation and facile cytosolic translocation of IgG in the presence of attenuated cationic amphiphilic lytic peptidesLiquid droplet formation and facile cytosolic translocation of IgG in the presence of attenuated cationic amphiphilic lytic peptides

Fc area binding peptide conjugated with attenuated cationic amphiphilic lytic peptide L17E trimer [FcB(L17E)3] was designed for immunoglobulin G (IgG) supply into cells. Particle-like liquid droplets have been generated by